ArticleFrontiers in oncology2023

Acrofacial vitiligo secondary to PI3KCA inhibitor, alpelisib: case report.

Maayan Geller Hinich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.